{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:13:48Z","timestamp":1790867628114,"version":"4.1.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Lobar cerebral microbleeds (CMBs) in Alzheimer's disease (AD) are associated with cerebral amyloid angiopathy (CAA) due to vascular amyloid beta (A\u03b2) deposits. However, the relationship between lobar CMBs and clinical subtypes of AD remains unknown. Here, we enrolled patients with early- and late-onset amnestic dominant AD, logopenic variant of primary progressive aphasia (lvPPA) and posterior cortical atrophy (PCA) who were compatible with the AD criteria. We then examined the levels of cerebrospinal fluid (CSF) biomarkers [A\u03b21-42, A\u03b21-40, A\u03b21-38, phosphorylated tau 181 (P-Tau), total tau (T-Tau), neurofilament light chain (NFL), and chitinase 3-like 1 protein (YKL-40)], analyzed the number and localization of CMBs, and measured the cerebral blood flow (CBF) volume by <jats:sup>99m<\/jats:sup>Tc-ethyl cysteinate dimer single photon emission computerized tomography (<jats:sup>99m<\/jats:sup>Tc ECD-SPECT), as well as the mean cortical standard uptake value ratio by <jats:sup>11<\/jats:sup>C-labeled Pittsburgh Compound B-positron emission tomography (<jats:sup>11<\/jats:sup>C PiB-PET). Lobar CMBs in lvPPA were distributed in the temporal, frontal, and parietal lobes with the left side predominance, while the CBF volume in lvPPA significantly decreased in the left temporal area, where the number of lobar CMBs and the CBF volumes showed a significant inversely correlation. The CSF levels of NFL in lvPPA were significantly higher compared to the other AD subtypes and non-demented subjects. The numbers of lobar CMBs significantly increased the CSF levels of NFL in the total AD patients, additionally, among AD subtypes, the CSF levels of NFL in lvPPA predominantly were higher by increasing number of lobar CMBs. On the other hand, the CSF levels of A\u03b21-38, A\u03b21-40, A\u03b21-42, P-Tau, and T-Tau were lower by increasing number of lobar CMBs in the total AD patients. These findings may suggest that aberrant brain hypoperfusion in lvPPA was derived from the brain atrophy due to neurodegeneration, and possibly may involve the aberrant microcirculation causing by lobar CMBs and cerebrovascular injuries, with the left side dominance, consequently leading to a clinical phenotype of logopenic variant.<\/jats:p>","DOI":"10.3389\/fneur.2021.543866","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T05:26:18Z","timestamp":1617686778000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Masaki","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Kodaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Takai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Makioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimitoshi","family":"Hirayanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minori","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Harigaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Nagamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Suto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasujiro","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakuni","family":"Amari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruyasu","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Takatama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/01.STR.18.2.311","article-title":"Cerebral amyloid angiopathy. A critical review","volume":"18","author":"Vinters","year":"1987","journal-title":"Stroke"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1212\/WNL.46.6.1751","article-title":"Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI","volume":"46","author":"Greenberg","year":"1996","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1212\/01.wnl.0000210535.20297.ae","article-title":"Prevalence and severity of microbleeds in a memory clinic setting","volume":"66","author":"Cordonnier","year":"2006","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ana.22516","article-title":"Cerebral amyloid angiopathy in the elderly","volume":"70","author":"Viswanathan","year":"2011","journal-title":"Ann Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1001\/archneur.65.6.790","article-title":"Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study","volume":"65","author":"Pettersen","year":"2008","journal-title":"Arch Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jamaneurol.2015.1359","article-title":"Incidental cerebral microbleeds and cerebral blood flow in elderly individuals","volume":"72","author":"Gregg","year":"2015","journal-title":"JAMA Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ana.91","article-title":"Primary progressive aphasia","volume":"49","author":"Mesulam","year":"2001","journal-title":"Ann Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3109\/13506129.2014.949231","article-title":"CSF levels of A\u03b21-38\/A\u03b21-40\/A\u03b21-42 and 11C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease","volume":"21","author":"Ikeda","year":"2014","journal-title":"Amyloid"},{"key":"B11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.neurobiolaging.2010.05.020","article-title":"Alzheimer's pathology in primary progressive aphasia","volume":"33","author":"Rohrer","year":"2012","journal-title":"Neurobiol Aging"},{"key":"B12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/archneur.1988.00520310107024","article-title":"Posterior cortical atrophy","volume":"45","author":"Benson","year":"1988","journal-title":"Arch Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(11)70289-7","article-title":"Posterior cortical atrophy","volume":"11","author":"Crutch","year":"2012","journal-title":"Lancet Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1212\/01.WNL.0000140289.18472.15","article-title":"Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy","volume":"63","author":"Tang-Wai","year":"2004","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"B16","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"B17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ana.21451","article-title":"Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia","volume":"64","author":"Rabinovici","year":"2008","journal-title":"Ann Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/brain\/aws327","article-title":"Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease","volume":"136","author":"Lehmann","year":"2013","journal-title":"Brain"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/jnnp.2010.207183","article-title":"Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias","volume":"82","author":"de Souza","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.neurobiolaging.2015.04.011","article-title":"Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease","volume":"36","author":"Ossenkoppele","year":"2015","journal-title":"Neurobiol Aging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1007\/s00415-015-7904-3","article-title":"Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis","volume":"262","author":"Paterson","year":"2015","journal-title":"J Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3233\/JAD-142628","article-title":"Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type","volume":"45","author":"Whitwell","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Dominantly inherited Alzheimer network. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e12005","DOI":"10.1002\/dad2.12005","article-title":"Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease","volume":"12","author":"Dhiman","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3233\/JAD-140624","article-title":"Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease","volume":"42","author":"Antonell","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3233\/JAD-191254","article-title":"Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy","volume":"74","author":"Banerjee","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","article-title":"The FAB: a frontal assessment battery at bedside","volume":"55","author":"Dubois","year":"2000","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1001\/jama.297.21.2391","article-title":"Does this patient have dementia?","volume":"297","author":"Holsinger","year":"2007","journal-title":"JAMA"},{"key":"B33","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/brain\/121.11.2083","article-title":"Prospective and retrospective studies of recovery in aphasia. Changes in cerebral blood flow and language functions","volume":"121","author":"Mimura","year":"1998","journal-title":"Brain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1044\/jshd.4503.308","article-title":"Reliability and validity characteristics of the Western Aphasia Battery (WAB)","volume":"45","author":"Shewan","year":"1980","journal-title":"J Speech Hear Disord."},{"key":"B36","volume-title":"Visual Perception Test for Agnosia","year":"1997"},{"key":"B37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/13506129.2013.790810","article-title":"Cerebrospinal fluid levels of phosphorylated tau and A\u03b21-38\/A\u03b21-40\/A\u03b21-42 in Alzheimer's disease with PS1 mutations","volume":"20","author":"Ikeda","year":"2013","journal-title":"Amyloid"},{"key":"B38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/archneur.58.3.373","article-title":"Evaluation of CSF-tau and CSF- A\u03b242 as diagnostic markers for Alzheimer's disease in clinical practice","volume":"58","author":"Andreasen","year":"2001","journal-title":"Arch Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3389\/fneur.2020.00757","article-title":"Increased neurofilament light chain and YKL-40 CSF levels in one Japanese IBMPFD patient with VCP R155C mutation: a clinical case report with CSF biomarker analyses","volume":"11","author":"Ikeda","year":"2020","journal-title":"Front Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer's fluid biomarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/14789450.2019.1628643","article-title":"The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development","volume":"16","author":"Baldacci","year":"2019","journal-title":"Expert Rev Proteomics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/WNL.0b013e3181c34a7d","article-title":"The microbleed anatomical rating scale (MARS): reliability of a tool to map brain microbleeds","volume":"73","author":"Gregoire","year":"2009","journal-title":"Neurology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/MNM.0b013e328013eb8b","article-title":"Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography","volume":"28","author":"Matsuda","year":"2007","journal-title":"Am J Neuroradiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/gps.4102","article-title":"Concordance between 99mTc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria","volume":"29","author":"Ito","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"B47","first-page":"1959","article-title":"Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis","volume":"46","author":"Lopresti","year":"2005","journal-title":"J Nucl Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2967\/jnumed.108.057612","article-title":"Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements","volume":"50","author":"McNamee","year":"2009","journal-title":"J Nucl Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s00259-016-3591-2","article-title":"Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI) multicenter study","volume":"44","author":"Yamane","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B50","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3233\/JAD-180939","article-title":"Deep white matter lesions are associated with early recognition of dementia in Alzheimer's disease","volume":"68","author":"Kasahara","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/0271678X15606141","article-title":"Cerebrospinal fluid profiles with increasing number of cerebral microbleeds in a continuum of cognitive impairment","volume":"36","author":"Shams","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"B52","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3233\/JAD-160651","article-title":"Cerebral amyloid angiopathy-related microbleeds and cerebrospinal fluid biomarkers in Alzheimer's disease","volume":"55","author":"Noguchi-Shinohara","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e1057","DOI":"10.1212\/WNL.0000000000005165","article-title":"Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias","volume":"90","author":"Mendes","year":"2018","journal-title":"Neurology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/acn3.518","article-title":"CSF neurogranin or tau distinguish typical and atypical Alzheimer disease","volume":"5","author":"Wellington","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-019-02036-6","article-title":"Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation","volume":"138","author":"Petersen","year":"2019","journal-title":"Acta Neuropathol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00401-007-0266-x","article-title":"Argyrophilic thorny astrocyte clusters in association with Alzheimer's disease pathology in possible primary progressive aphasia","volume":"114","author":"Munoz","year":"2007","journal-title":"Acta Neuropathol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e1353","DOI":"10.1212\/WNL.0000000000008937","article-title":"Language and spatial dysfunction in Alzheimer disease with white matter thorn-shaped astrocytes","volume":"94","author":"Resende","year":"2020","journal-title":"Neurology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/ene.14594","article-title":"Association of amyloid angiopathy with microbleeds in logopenic progressive aphasia: an imaging-pathology study","volume":"28","author":"Buciuc","year":"2021","journal-title":"Eur J Neurol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1212\/WNL.0000000000002419","article-title":"Heterogeneous histopathology of cortical microbleeds in cerebral amyloid angiopathy","volume":"86","author":"van Veluw","year":"2016","journal-title":"Neurology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.neurobiolaging.2014.12.013","article-title":"Working memory and language network dysfunctions in logopenic aphasia: a task-free fMRI comparison with Alzheimer's dementia","volume":"36","author":"Whitwell","year":"2015","journal-title":"Neurobiol Aging"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.543866\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T05:26:23Z","timestamp":1617686783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.543866\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":60,"alternative-id":["10.3389\/fneur.2021.543866"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.543866","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"article-number":"543866"}}